General Information of This Antibody
Antibody ID
ANTI0CTVJD
Antibody Name
8D9
Organization
XADCERA BIOPHARMACEUTICAL (SUZHOU) CO., LTD.
Synonyms
8D9
   Click to Show/Hide
Antigen Name
Trophoblast glycoprotein (TPBG)
 Antigen Info 
Click to Show/Hide the Sequence Information of This Antibody
Heavy Chain CDR 1
GHYWS
    Click to Show/Hide
Heavy Chain CDR 2
YITYSGSTNYNPSLKS
    Click to Show/Hide
Heavy Chain CDR 3
IAVAGRVYYYGVDV
    Click to Show/Hide
Light Chain CDR 1
RASQSVSSYLA
    Click to Show/Hide
Light Chain CDR 2
DASNRAT
    Click to Show/Hide
Light Chain CDR 3
QQRSNWPPT
    Click to Show/Hide
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
WO2024193682A1 8D9-ADC [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) > 100 ug/ml
Method Description
Series diluted ADCs (maximum concentration: 20 ug/mL, 3-fold dilutions, 10 gradients)were used to treat human lung squamous carcinoma NCI-H226 5000cells cultured in a cellculture plate, and the killing activity was detected after 72 hours of incubation in IncuCyte (Sartorius AG, IncuCytee S3).
In Vitro Model Pleural epithelioid mesothelioma NCI-H226 cells CVCL_1544
References
Ref 1 Anti-TPBG/MET antibodies and uses thereof